Literature DB >> 29631419

Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.

Dong-Hyun Choi1, Yuhei Kobayashi2, Takeshi Nishi2, Hyun Kuk Kim1, Young-Jae Ki1, Sung Soo Kim1, Keun-Ho Park1, Heesang Song3, William F Fearon2.   

Abstract

We hypothesized that the combination of a high neutrophil to lymphocyte ratio (NLR) and mean platelet volume (MPV) would be a stronger predictor of future cardiovascular events after percutaneous coronary intervention (PCI). Both NLR and MPV were measured in 364 consecutive patients undergoing PCI. The primary end point was the incidence of major adverse cardiovascular events (MACEs), including cardiac death, nonfatal myocardial infarction, and stent thrombosis. The median values of NLR and MPV were 2.8 and 8.2 fL, respectively. There were 26 MACEs during a median follow-up duration of 29.3 months. Kaplan-Meier analysis revealed that the higher NLR group had a significantly higher MACE rate than the lower NLR group and that the higher MPV group had a significantly higher MACE rate than the lower MPV group (log-rank: P = .0064 and P = .0004, respectively). The cumulative MACE-free survival can be further stratified by the combination of NLR and MPV. This value was especially useful in patients with acute coronary syndrome (ACS). By multivariate Cox proportional hazards model, the combination of high NLR and high MPV was independently associated with MACE ( P = .026). The combination of a high NLR and high MPV is an independent predictor of MACE after PCI, especially in patients with ACS.

Entities:  

Keywords:  MACE; mean platelet volume; neutrophil to lymphocyte ratio; percutaneous coronary intervention

Mesh:

Year:  2018        PMID: 29631419     DOI: 10.1177/0003319718768658

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  4 in total

1.  Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study.

Authors:  Yi Yang; Yanan Xu; Jun Wang; Xueqin Zhai; Haibing Jiang
Journal:  BMC Cardiovasc Disord       Date:  2020-11-30       Impact factor: 2.298

2.  Changes in the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios before and after percutaneous coronary intervention and their impact on the prognosis of patients with acute coronary syndrome.

Authors:  Jianlong Sheng; Nina Liu; Fei He; Cheng Cheng; Shichun Shen; Yuting Sun
Journal:  Clinics (Sao Paulo)       Date:  2021-08-04       Impact factor: 2.365

3.  Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients.

Authors:  Qiuxuan Li; Xiaoteng Ma; Qiaoyu Shao; Zhiqiang Yang; Yufei Wang; Fei Gao; Yujie Zhou; Lixia Yang; Zhijian Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-03

4.  The White Blood Cell Count to Mean Platelet Volume Ratio for the Prediction of Chronic Limb-Threatening Ischemia in Lower Extremity Artery Disease.

Authors:  Katharina Guetl; Reinhard Bernd Raggam; Viktoria Muster; Paul Gressenberger; Jovan Vujic; Alexander Avian; Franz Hafner; Martin Wehrschuetz; Marianne Brodmann; Thomas Gary
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.